XML 79 R63.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTIES (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Jul. 14, 2021
Jan. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
May 04, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Accrued royalties     $ 1,771,219 $ 856,755  
Cash         $ 500,000
Asset Purchase Agreement [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Cash $ 496,100        
Common stock shares issued 14,369        
Consulting Agreement [Member] | Ms Salamone [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Professional Fees $ 177,697        
Cellerate Rx Sub License Agreement [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Net sale   $ 1,000,000      
License agreement and royalties description   The Company pays royalties based on the annual Net Sales of licensed products (as defined in the sublicense agreement) consisting of 3% of all collected Net Sales each year up to $12,000,000, 4% of all collected Net Sales each year that exceed $12,000,000 up to $20,000,000, and 5% of all collected Net Sales each year that exceed $20,000,000.      
Cellerate Rx Sub License Agreement [Member] | Cost of Sales [Member]          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Accrued royalties     $ 1,771,219 $ 856,755